![](/img/cover-not-exists.png)
Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden
Bernfort, Lars, Husberg, Magnus, Wiréhn, Ann-Britt, Rosenqvist, Ulf, Gustavsson, Staffan, Karlsdotter, Kristina, Levin, Lars-à keJournal:
Diabetes Therapy
DOI:
10.1007/s13300-020-00937-4
Date:
October, 2020
File:
PDF, 382 KB
2020